Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan for Albuminuria in Hypertensive T2DM
NCT00550095Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in diabetic nephropathy (DN), hypertension (HTN), sponsored by Novartis. Started Jun 2007; status: completed.
02
Drugs
valsartan
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00550095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550095.